SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014735
Filing Date
2022-08-04
Accepted
2022-08-04 16:07:09
Documents
78
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-20220630.htm   iXBRL 10-Q 4237899
2 EX-31.1 dvax-ex31_1.htm EX-31.1 17353
3 EX-31.2 dvax-ex31_2.htm EX-31.2 17024
4 EX-32.1 dvax-ex32_1.htm EX-32.1 11203
5 EX-32.2 dvax-ex32_2.htm EX-32.2 11617
  Complete submission text file 0000950170-22-014735.txt   14914568

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20220630_lab.xml EX-101.LAB 615397
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20220630.xsd EX-101.SCH 78253
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20220630_pre.xml EX-101.PRE 476898
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dvax-20220630_def.xml EX-101.DEF 320390
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dvax-20220630_cal.xml EX-101.CAL 68955
72 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20220630_htm.xml XML 3358468
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 221136528
SIC: 2834 Pharmaceutical Preparations